Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production
about
The rationale for BAFF inhibition in systemic lupus erythematosusResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentInterplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostThe potential utility of B cell-directed biologic therapy in autoimmune diseases.Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.Helicobacter pylori promotes the production of thymic stromal lymphopoietin by gastric epithelial cells and induces dendritic cell-mediated inflammatory Th2 responses.The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors.Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartmentsIFN-β treatment requires B cells for efficacy in neuroautoimmunity.Innate endogenous adjuvants prime to desirable immune responses via mucosal routesCigarette smoke inhibits BAFF expression and mucosal immunoglobulin A responses in the lung during influenza virus infectionSignaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseDifferential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.Effect of uremia on structure and function of immune system.BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosusThe impact of inflammation and immune activation on B cell differentiation during HIV-1 infection.BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cellsBLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses.B-cell activating factor targeted therapy and lupus.Evaluation of renal function and immune system cells in elderly individuals from São Paulo CitySignaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosaThe BLyS family: toward a molecular understanding of B cell homeostasis.BAFF: a local and systemic target in autoimmune diseases.B cells as therapeutic targets in SLE.The role of notch signaling in the development of a normal B-cell repertoire.Therapeutic implications of advances in our understanding of transitional B-cell development in humans.Targeting BAFF in autoimmunity.Targeting BLyS in rheumatic disease: the sometimes-bumpy road from bench to bedside.BAFF inhibition: a new class of drugs for the treatment of autoimmunity.Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in miceB-cell-activating factor and autoimmune myasthenia gravis.Development of targeted adjuvants for HIV-1 vaccinesThe receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF.Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations.
P2860
Q26827373-6347148C-CE76-44C9-B568-C5734A4900ACQ26852927-284E0178-1215-44E9-8274-EB9E2E5D705CQ28080198-F9C2B6B1-3E04-4922-9B21-0805C937030AQ33377109-ED2FBDDF-251D-4779-8251-83930529300CQ33552202-4AA1D90E-39CE-4457-8B8E-0307AB6EAD57Q33557805-ECDD816A-23CA-49BD-A5C2-F0277D775724Q34580751-23BCB2AD-74CD-44D4-AD31-9C58B7A97FACQ35058903-61DDB300-B6BE-4715-A40F-881E4B546480Q35122216-CCEC7898-AAEE-4EE4-B5DA-9F3533B98020Q35143128-45647288-691A-4353-B38E-446CAB4239EFQ35190343-C997870B-289F-40E4-8CFB-7F187E418E8BQ35452032-0F8232E4-FFA4-49E2-8B2D-819914E6CA98Q35630042-0B0C1BA0-F3AB-4810-B8F3-5885EADC8680Q35635884-B16E48EF-8AA4-44AC-AF11-B82CC3301DB6Q35686772-7C6D069E-5DDE-4246-B8CE-BE212C8E45ECQ35928324-CE4149D7-6923-49A2-90C1-2F77B654770BQ35951005-8EEB5727-E907-4DB2-957C-7750951EC31AQ36016522-36C9D6D6-816C-4EBF-99EE-9EBE9B0A6E9CQ36504641-B5483B5F-2395-4B75-B1D6-80F1444DF326Q36555073-9C0D748D-8D5C-4979-89F9-C6A13BBB0864Q36579827-C0FBD0AB-7304-496F-8469-550DD4346D14Q37192183-05B998F5-D2FB-478C-B4C8-720089C9E74DQ37256524-11113850-AB57-49BA-B02B-F438A156E703Q37335169-7D85E7C4-8BA5-4461-BC9F-B3889411B94BQ37593590-C5B1F11F-007C-41EC-8BE5-329CF08D4EC3Q37603296-9662E076-764B-436B-A473-A49E736F15CFQ37608930-2096100B-D729-47FB-86B4-D2411F3F0D81Q37786629-371FE2D1-18F5-46EA-8217-08CDF8E21B72Q37802627-6DE65F53-2322-4E3F-A6D0-A9CA54D5F9DAQ37844395-9C6AFA63-8FA1-48A7-9C8E-5D1F46ADF35CQ37844764-04AE8E58-2270-4BF1-AF88-0499C39F7EE3Q39985668-51D02524-6D3D-4E5D-8C3E-404B3F552862Q40179681-D32B91D4-568E-414A-A7D7-3187D32F0D66Q41277922-A23A08E7-134F-4B35-8CFD-F7F0719103EEQ41458895-5426214E-DA3F-435B-82D7-F0E9BEC476E2Q42937083-E06A7B7B-3668-4FA3-99B1-BAEF5444694CQ47195254-F8BDB22F-ED36-4020-B7E2-90CAA7FE120EQ53644910-689D65F0-BC1E-43F2-92D1-B20416E2E428
P2860
Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@ast
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@en
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@nl
type
label
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@ast
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@en
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@nl
prefLabel
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@ast
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@en
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@nl
P3181
P1476
Impact of the BAFF/BR3 axis on ...... enance and antibody production
@en
P2093
Susan L Kalled
P3181
P356
10.1016/J.SMIM.2006.06.002
P407
P577
2006-10-01T00:00:00Z